Depression During Pregnancy Affect Infant’s Brain Anatomy, But No Change with Prenatal Exposure to SSRIs
Infants exposed to maternal depression during pregnancy had significantly larger subcortical grey matter volumes and smaller midbrain volumes.
In Brief: Postpartum Depression Common in COVID-Positive Women Separated from Their Newborns
Women may experience depression and post-traumatic symptoms, especially those who were separated from their newborns after delivery and those with severe COVID-19 illness during pregnancy or after delivery.
Essential Reads: A Clinical Guide for the Diagnosis and Treatment of PMDD
In an evidence-based review published in 2012, Laura Wakil, Samantha Meltzer-Brody, and Susan Girdler present a thorough review of premenstrual dysphoric disorder (PMDD), reviewing its diagnosis and treatment options.
Cannabis Use is Legal in Many States, But That Doesn’t Mean It’s Safe to Use During Pregnancy
Heavy cannabis use during pregnancy was associated with increased risk for small for gestational age, preterm birth, low birth weight, and death during the first year of life.
Weekly Roundup for June 11, 2021: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. For more detailed descriptions of many of these topics, you [...]
Why We Need to Discuss the COVID-19 Vaccine with Women of Childbearing Age
ACOG clearly states that all pregnant and lactating people should be allowed to receive the COVID-19 vaccine, and that their decision to do so should be based on a careful discussion of risks and benefits with their healthcare provider.
Essential Reads: Stress, Anxiety and Depression in Couples Undergoing Infertility Treatment
Individuals experiencing significant infertility-related psychological symptoms are less likely to pursue infertility treatment and more likely to drop out.
In Women with Opioid Use Disorder, Treatment Initiated During Pregnancy May Improve Postpartum Outcomes
This study demonstrates higher rates of treatment continuation in postpartum women with opioid use disorders if medication treatment (methadone or buprenorphine) is initiated early and maintained throughout pregnancy.